InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Mattessich Antony C., 董事长兼首席执行官. Director active across 3 companies, notably OCULAR THERAPEUTIX, INC. In total, 10 disclosures have been published. Split: 2 buys · 2 sells. Total volume traded: €226k. History available since 20 August 2021. The latest transaction was filed on 17 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Mattessich Antony C. is Chairman and Chief Executive Officer. He appears in 10 filings, and, across the sampled recent filings between 2021-08-24 and 2026-06-15, the aggregated amounts are EUR 65002 of buys and EUR 160997 of sells. His listed companies are Ocular Therapeutix, INC, where he is President and CEO, and Aura Biosciences, Inc., where he is Director, with the modal transaction nature shown as Attribution.